141st APHA Annual Meeting and Exposition

Home Events & Meetings Annual Meeting Schedule & Program

Recorded Annual Meeting Presentations (RAMP) are now available for purchase.
Only $90 for presenters, $140 for registered attendees and $200 for non-attendees.

Online Program

294942
Strategies to Address Prescription Drug Misuse and Abuse


Monday, November 4, 2013 : 8:50 a.m. - 9:10 a.m.

H. Westley Clark, MD, JD, MPH, CAS, FASAM, Center for Substance Abuse Treatment, Substance Abuse and Mental Health Services Administration, Rockville, MD
        
According to the 2011 National Survey on Drug Use and Health (NSDUH), 6.1 million persons (aged 12 and over) reported nonmedical use of a psychotherapeutic in the past month – second only to reported marijuana use. Nonmedical use of pain relievers made up the largest portion of that population, or 4.5 million people. Dr. Clark will focus on the trends and risk factors regarding prescription drug misuse/abuse based on the NSDUH, Drug Abuse Warning Network (DAWN), and Treatment Episode Data Set (TEDS). He will also discuss SAMHSA's role regarding treatment with methadone and buprenorphine and will overview effective policies and activities to reduce/eliminate diversion.

Learning Areas:

Clinical medicine applied in public health
Epidemiology
Public health or related laws, regulations, standards, or guidelines
Public health or related public policy
Social and behavioral sciences
Systems thinking models (conceptual and theoretical models), applications related to public health

Learning Objectives:
Identify the trends regarding prescription drug misuse and abuse based on the National Survey of Drug Use and Health, Drug Abuse Warning Network, and the Treatment Episode Data Set. Define the risk factors for potential misuse or abuse or prescription medications. - Demonstrate the current trends and challenges regarding treatment with methadone and buprenorphine - Describe the effective policies and activities to reduce/eliminate diversion. Define evidence-based practices and understand their importance Define the potential impact of Health Reform and SAMHSA’s role regarding behavioral health and the ACA.

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: As director of the Center for Substance Abuse Treatment under the Substance Abuse and Mental Health Services Administration, U.S. Department of Health and Human Services, Dr. H. Westley Clark leads the agency's efforts to provide effective and accessible treatment to all Americans with addictive disorders. Dr. Clark's areas of expertise include substance abuse treatment, methadone maintenance, pain management, dual diagnosis, psychopharmacology, anger management, and medical and legal issues.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.

Back to: 3010.0: Prescription Drug Overdoses: Emerging Best Practices for Prevention